Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Triple Negative Breast Neoplasms

fluorodeoxyglucose f18 has been researched along with Triple Negative Breast Neoplasms in 47 studies

Research

Studies (47)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's28 (59.57)24.3611
2020's19 (40.43)2.80

Authors

AuthorsStudies
Choi, YJ; Kang, T; Kim, H; Kim, IJ; Kim, K; Pak, K; Seol, YM1
Dong, Z; Kotagiri, N; Mahoney, M; Singaravelu, I; Spitz, H1
Gong, C; Hu, S; Hu, X; Li, Y; Liu, C; Song, S; Wang, B; Xie, Y; Yang, Z; Zhao, Y1
Bhoriwal, S; Ephraim, R; Kar, M; Muduly, DK; Pathak, M; Ray, S; Sultania, M1
Erdil, TY; Filizoglu, N; Ozguven, S1
Cheon, GJ; Choi, H; Han, W; Kang, KW; Lee, HB; Lee, R; Paeng, JC; Seok, JW; Whi, W1
Arihiro, K; Emi, A; Kadoya, T; Kimura, Y; Masumoto, N; Okada, M; Sasada, S1
Cao, G; Fan, H; Liu, Y; Shao, W; Shi, X; Wang, W; Zhang, J1
Chae, SY; Gong, G; Han, S; Lee, J; Lee, SB; Moon, DH; Oh, JS1
Akbas, S; Arslan, E; Battal Havare, S; Beyhan, E; Can Trabulus, FD; Cin, M; Ergül, N; Erol Fenercioglu, Ö; Fikret Çermik, T; Mermut, Ö; Sahin, R1
Huang, G; Liu, J; Meng, H; Wang, C; Wen, J; Zhao, H1
Fettig, N; Li, S; Luo, J; Prmeau, T; Roy, S; Savaikar, MA; Shoghi, KI; Strong, L; Wahl, RL; Whitehead, T1
Deng, S; He, Y; Liu, H; Liu, S; Sun, H; Weng, Z; Yang, J; Zhang, B; Zuo, B1
Laffon, E; Marthan, R1
Jeong, WG; Ki, SY; Kwon, SY; Lee, HJ; Lee, JE; Lee, JS; Lim, HS; Park, HM; Park, MH; Shin, SS1
De Meulenaere, V; De Wever, O; Deblaere, K; Descamps, B; Vanhove, C1
Gao, Q; Li, X; Liu, J; Wang, Z; Xia, Y; Xu, T1
Ademuyiwa, FO; Dehdashti, F; Li, S; Roy, S; Shoghi, KI; Wahl, RL; Whitehead, TD1
Aime, S; Anemone, A; Bracesco, M; Capozza, M; Della Peruta, M; Dhakan, C; Longo, DL; Terreno, E; Villano, D; Zullino, S1
Gilhuijs, KG; Koolen, BB; Pengel, KE; Rodenhuis, S; Rutgers, EJ; Sonke, GS; Teixeira, SC; Valdés Olmos, RA; van Ramshorst, MS; Vogel, WV; Vrancken Peeters, MT; Wesseling, J1
Cheon, GJ; Chung, JK; Kang, KW; Kim, YI; Kim, YJ; Lee, DS; Paeng, JC1
Abdel-Atti, D; Dilling, TR; Edwards, KJ; Evans, MJ; Henry, KE; Lewis, JS1
Akimoto, E; Emi, A; Kadoya, T; Kajitani, K; Masumoto, N; Ohara, M; Okada, M; Shigematsu, H1
Drude, N; Miran, T; Morgenroth, A; Mottaghy, FM; Vogg, ATJ1
Hanaoka, H; Kartamihardja, AAP; Nakajima, T; Nguyen-Cong, T; Nguyen-Thu, H; Tsushima, Y; Yamaguchi, A1
Bertheau, P; Biard, L; Bouhidel, FA; de Cremoux, P; Espié, M; Groheux, D; Lehmann-Che, J; Merlet, P; Poirot, B; Resche-Rigon, M; Sotiriou, C; Teixeira, L1
Groheux, D1
Belloli, S; Bogni, A; Bombardieri, E; Daidone, MG; Moresco, RM; Pascali, C; Presotto, L; Raccagni, I; Russo, G; Stefano, A; Tortoreto, M; Valtorta, S; Zaffaroni, N1
Choi, BB; Kim, KH; Lee, JS1
Brunotte, F; Cochet, A; Coutant, C; Grapin, M; Humbert, O; Ladoire, S; Riedinger, JM1
Gilhuijs, KG; Koolen, BB; Pengel, KE; Rodenhuis, S; Rutgers, EJ; Valdés Olmos, RA; Vincent, AD; Vogel, WV; Vrancken Peeters, MJ; Wesseling, J2
Emi, A; Kadoya, T; Masumoto, N; Ohara, M; Okada, M; Ozaki, S; Shigematsu, H; Tsutani, Y1
Engebråten, O; Kristian, A; Malinen, E; Mælandsmo, GM; Qu, H; Revheim, ME; Seierstad, T1
Kataoka, M; Kiyoto, S; Mochizuki, T; Nakajima, N; Ochi, T; Ohsumi, S; Sugawara, Y1
Bae, MS; Chang, JM; Cho, N; Kang, KW; Kim, JY; Kim, MY; Kim, WH; Koo, HR; Lee, SH; Moon, WK; Park, JS; Seo, M1
Boubaya, M; Buvat, I; Eder, V; Orlhac, F; Soussan, M; Zelek, L; Ziol, M1
Berger, F; de Cremoux, P; de Roquancourt, A; Espié, M; Giacchetti, S; Groheux, D; Hamy, AS; Hatt, M; Hindié, E; Marty, M; Merlet, P1
Han, W; Kang, KW; Koo, HR; Moon, WK; Park, IA; Park, JS1
Semiglazov, V1
Berriolo-Riedinger, A; Brunotte, F; Charon-Barra, C; Cochet, A; Coutant, C; Desmoulins, I; Fumoleau, P; Humbert, O; Kanoun, S; Lorgis, V; Riedinger, JM1
Kristian, A; Malinen, E; Pitman, KE; Rusten, E1
Audeh, W; Bose, S; Cui, X; Fraass, B; Yue, Y; Zhang, X1
Biard, L; Cuvier, C; de Cremoux, P; de Roquancourt, A; Espié, M; Giacchetti, S; Groheux, D; Hindié, E; Merlet, P; Resche-Rigon, M; Teixeira, L; Vercellino, L1
Berriolo-Riedinger, A; Brunotte, F; Cochet, A; Depardon, E; Dygai-Cochet, I; Fumoleau, P; Humbert, O; Kanoun, S; Lassere, M; Riedinger, JM; Tisserand, S; Toubeau, M; Vrigneaud, JM1
Castillo, R; Goldman, DA; Gönen, M; Jochelson, MS; Pinker-Domenig, K; Riedl, CC; Ulaner, GA; Wills, J1
Bach-Gansmo, T; Bogsrud, TV; Grad, I; Haraldsen, I; Munthe, E; Riss, PJ; Saga, TA1

Trials

2 trial(s) available for fluorodeoxyglucose f18 and Triple Negative Breast Neoplasms

ArticleYear
Co-clinical FDG-PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple-negative breast cancer.
    European journal of nuclear medicine and molecular imaging, 2022, Volume: 49, Issue:2

    Topics: Bayes Theorem; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Reproducibility of Results; Triple Negative Breast Neoplasms

2022
18F-FDG PET-Derived Tumor Blood Flow Changes After 1 Cycle of Neoadjuvant Chemotherapy Predicts Outcome in Triple-Negative Breast Cancer.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016, Volume: 57, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Angiography; Antineoplastic Agents; Blood Flow Velocity; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Neovascularization, Pathologic; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Triple Negative Breast Neoplasms

2016

Other Studies

45 other study(ies) available for fluorodeoxyglucose f18 and Triple Negative Breast Neoplasms

ArticleYear
Prognostic value of metabolic activity of the psoas muscle evaluated by preoperative
    BMC cancer, 2021, Oct-27, Volume: 21, Issue:1

    Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Insulin Resistance; Liver; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Preoperative Care; Prognosis; Proportional Hazards Models; Psoas Muscles; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Triple Negative Breast Neoplasms

2021
Antiandrogen Therapy Radiosensitizes Androgen Receptor-Positive Cancers to
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2022, Volume: 63, Issue:8

    Topics: Androgen Antagonists; Animals; Cell Line, Tumor; Fluorodeoxyglucose F18; Humans; Mice; Nitriles; Radiation-Sensitizing Agents; Receptors, Androgen; Triple Negative Breast Neoplasms; Ultraviolet Rays

2022
Heterogeneity derived from
    Cancer medicine, 2022, Volume: 11, Issue:9

    Topics: Fluorodeoxyglucose F18; Humans; Immunotherapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Triple Negative Breast Neoplasms

2022
Correlation of 18-fluorodeoxyglucose uptake values on PET-CT scan with histological prognostic markers in breast cancer.
    Asia-Pacific journal of clinical oncology, 2023, Volume: 19, Issue:2

    Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Triple Negative Breast Neoplasms

2023
18F-FDG PET/CT Metabolic Response With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Treated With Cyclin-Dependent 4/6 Kinase Inhibitors.
    Clinical nuclear medicine, 2022, Sep-01, Volume: 47, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclins; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Receptor, ErbB-2; Triple Negative Breast Neoplasms

2022
Association of androgen receptor expression with glucose metabolic features in triple-negative breast cancer.
    PloS one, 2022, Volume: 17, Issue:9

    Topics: Androgens; Female; Fluorodeoxyglucose F18; Gene Expression; Glucose; Humans; Prognosis; Receptors, Androgen; Retrospective Studies; Triple Negative Breast Neoplasms

2022
    Anticancer research, 2023, Volume: 43, Issue:1

    Topics: B7-H1 Antigen; Fluorodeoxyglucose F18; Forkhead Transcription Factors; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Programmed Cell Death 1 Receptor; Triple Negative Breast Neoplasms; Tumor Microenvironment

2023
Prediction of Clinical Molecular Typing of Breast Invasive Ductal Carcinoma Using
    Academic radiology, 2023, Volume: 30 Suppl 2

    Topics: Breast Neoplasms; Carcinoma, Ductal; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Triple Negative Breast Neoplasms

2023
Prognostic significance of pretreatment
    Breast cancer research and treatment, 2023, Volume: 198, Issue:2

    Topics: Breast Neoplasms; Chemotherapy, Adjuvant; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Retrospective Studies; Triple Negative Breast Neoplasms

2023
The roles of 68 Ga-PSMA PET/CT and 18 F-FDG PET/CT imaging in patients with triple-negative breast cancer and the association of tissue PSMA and claudin 1, 4, and 7 levels with PET findings.
    Nuclear medicine communications, 2023, Apr-01, Volume: 44, Issue:4

    Topics: Claudin-1; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphatic Metastasis; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed; Triple Negative Breast Neoplasms

2023
Noninvasive Classification of Human Triple Negative Breast Cancer by PET Imaging with GRP78-Targeted Molecular Probe [
    Molecular imaging and biology, 2020, Volume: 22, Issue:3

    Topics: Animals; Cell Line, Tumor; Endoplasmic Reticulum Chaperone BiP; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Heat-Shock Proteins; Humans; Mice; Mice, Nude; Molecular Probes; Radiochemistry; Radiopharmaceuticals; Tissue Distribution; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2020
Preclinical PERCIST and 25% of SUV
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020, Volume: 61, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Heterografts; Humans; Mice; Neoplasm Transplantation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Triple Negative Breast Neoplasms

2020
    Breast cancer (Tokyo, Japan), 2020, Volume: 27, Issue:3

    Topics: Albendazole; Animals; Apoptosis; Cell Movement; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Triple Negative Breast Neoplasms; Tubulin Modulators; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2020
SUV
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020, Volume: 61, Issue:9

    Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Heterografts; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Triple Negative Breast Neoplasms

2020
18F-fluorodeoxyglucose uptake on PET/computed tomography in association with androgen receptor expression and other clinicopathologic factors in surgically resected triple-negative breast cancer.
    Nuclear medicine communications, 2021, Volume: 42, Issue:1

    Topics: Adult; Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Receptors, Androgen; Triple Negative Breast Neoplasms

2021
In vivo selection of the MDA-MB-231br/eGFP cancer cell line to obtain a clinically relevant rat model for triple negative breast cancer brain metastasis.
    PloS one, 2020, Volume: 15, Issue:12

    Topics: Animals; Bone Neoplasms; Brain Neoplasms; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Green Fluorescent Proteins; Humans; Magnetic Resonance Imaging; Neoplasm Transplantation; Rats; Rats, Nude; Serial Passage; Triple Negative Breast Neoplasms

2020
Integrated analysis reveals the participation of IL4I1, ITGB7, and FUT7 in reshaping the TNBC immune microenvironment by targeting glycolysis.
    Annals of medicine, 2021, Volume: 53, Issue:1

    Topics: Fluorodeoxyglucose F18; Fucosyltransferases; Glucose; Glycolysis; Humans; Integrin beta Chains; L-Amino Acid Oxidase; Triple Negative Breast Neoplasms; Tumor Microenvironment

2021
GlucoCEST MRI for the Evaluation Response to Chemotherapeutic and Metabolic Treatments in a Murine Triple-Negative Breast Cancer: A Comparison with[
    Molecular imaging and biology, 2022, Volume: 24, Issue:1

    Topics: Animals; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mice; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Triple Negative Breast Neoplasms

2022
Additional value of
    Cancer imaging : the official publication of the International Cancer Imaging Society, 2017, May-25, Volume: 17, Issue:1

    Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Triple Negative Breast Neoplasms

2017
Prediction of breast cancer recurrence using lymph node metabolic and volumetric parameters from
    European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:11

    Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Triple Negative Breast Neoplasms

2017
Noninvasive
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018, Volume: 59, Issue:1

    Topics: Animals; Biological Transport; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Mice; Positron-Emission Tomography; Proto-Oncogene Proteins c-myc; Radioisotopes; Transferrin; Triple Negative Breast Neoplasms; Zirconium

2018
Role of
    Clinical breast cancer, 2018, Volume: 18, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Postoperative Period; Predictive Value of Tests; Preoperative Period; Prognosis; Prospective Studies; Radiopharmaceuticals; Receptor, ErbB-2; ROC Curve; Triple Negative Breast Neoplasms

2018
Modulation of glutathione promotes apoptosis in triple-negative breast cancer cells.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2018, Volume: 32, Issue:5

    Topics: Animals; Buthionine Sulfoximine; Cell Line, Tumor; Deoxyuridine; DNA Breaks, Double-Stranded; Female; Fluorodeoxyglucose F18; Glutathione; Humans; Mice; Mice, Nude; Promoter Regions, Genetic; Reactive Oxygen Species; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2018
Early prediction of triple negative breast cancer response to cisplatin treatment using diffusion-weighted MRI and
    Breast cancer (Tokyo, Japan), 2018, Volume: 25, Issue:3

    Topics: Animals; Antineoplastic Agents; Breast; Cell Line, Tumor; Cisplatin; Diffusion Magnetic Resonance Imaging; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Treatment Outcome; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2018
Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancer.
    European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:8

    Topics: Cell Proliferation; Fluorodeoxyglucose F18; Genomics; Humans; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Triple Negative Breast Neoplasms

2018
Now Is the Time to Use
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018, Volume: 59, Issue:6

    Topics: Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Triple Negative Breast Neoplasms

2018
[18F]FDG and [18F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer.
    PloS one, 2018, Volume: 13, Issue:5

    Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Mice; Mice, Nude; Mice, SCID; Neoadjuvant Therapy; Paclitaxel; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Thymidine; Transplantation, Heterologous; Triple Negative Breast Neoplasms

2018
Association between MRI Features and Standardized Uptake Value of 18F-FDG PET/CT in Triple-Negative Breast Cancer.
    Oncology research and treatment, 2018, Volume: 41, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Breast; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Triple Negative Breast Neoplasms

2018
Combination of breast imaging parameters obtained from
    European journal of radiology, 2019, Volume: 113

    Topics: Adult; Aged; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Mastectomy; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed; Triple Negative Breast Neoplasms

2019
FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancer.
    Breast (Edinburgh, Scotland), 2013, Volume: 22, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; ROC Curve; Tomography, X-Ray Computed; Triple Negative Breast Neoplasms

2013
Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer.
    Breast (Edinburgh, Scotland), 2013, Volume: 22, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Ductal, Breast; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Triple Negative Breast Neoplasms

2013
Sequential (18)F-FDG PET/CT for early prediction of complete pathological response in breast and axilla during neoadjuvant chemotherapy.
    European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:1

    Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Receptor, ErbB-2; Receptors, Estrogen; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Triple Negative Breast Neoplasms

2014
Dynamic (18)F-FDG-PET for monitoring treatment effect following anti-angiogenic therapy in triple-negative breast cancer xenografts.
    Acta oncologica (Stockholm, Sweden), 2013, Volume: 52, Issue:7

    Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Mice; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Triple Negative Breast Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays

2013
Volume-based parameters of 18F-fluorodeoxyglucose positron emission tomography/computed tomography improve disease recurrence prediction in postmastectomy breast cancer patients with 1 to 3 positive axillary lymph nodes.
    International journal of radiation oncology, biology, physics, 2013, Nov-15, Volume: 87, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Agents; Axilla; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Care; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Receptors, Estrogen; Risk Assessment; ROC Curve; Tomography, X-Ray Computed; Triple Negative Breast Neoplasms; Tumor Burden

2013
18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes.
    European radiology, 2014, Volume: 24, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Retrospective Studies; Tomography, X-Ray Computed; Triple Negative Breast Neoplasms; Young Adult

2014
Relationship between tumor heterogeneity measured on FDG-PET/CT and pathological prognostic factors in invasive breast cancer.
    PloS one, 2014, Volume: 9, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Immunohistochemistry; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed; Triple Negative Breast Neoplasms

2014
Early assessment with 18F-fluorodeoxyglucose positron emission tomography/computed tomography can help predict the outcome of neoadjuvant chemotherapy in triple negative breast cancer.
    European journal of cancer (Oxford, England : 1990), 2014, Volume: 50, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Taxoids; Tomography, X-Ray Computed; Treatment Outcome; Triple Negative Breast Neoplasms

2014
Correlation between (18)F-FDG uptake on PET/CT and prognostic factors in triple-negative breast cancer.
    European radiology, 2015, Volume: 25, Issue:11

    Topics: Adult; Aged; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Triple Negative Breast Neoplasms; Tumor Burden

2015
RECIST for Response (Clinical and Imaging) in Neoadjuvant Clinical Trials in Operable Breast Cancer.
    Journal of the National Cancer Institute. Monographs, 2015, Volume: 2015, Issue:51

    Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammography; Neoadjuvant Therapy; Positron-Emission Tomography; Reproducibility of Results; Response Evaluation Criteria in Solid Tumors; Sensitivity and Specificity; Triple Negative Breast Neoplasms

2015
Identification of Biomarkers Including 18FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2015, Dec-15, Volume: 21, Issue:24

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biomarkers, Tumor; Biopsy; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Prognosis; ROC Curve; Tomography, X-Ray Computed; Treatment Outcome; Triple Negative Breast Neoplasms; Tumor Burden

2015
Variability of dynamic 18F-FDG-PET data in breast cancer xenografts.
    Acta oncologica (Stockholm, Sweden), 2015, Volume: 54, Issue:9

    Topics: Animals; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Heterografts; Mammary Neoplasms, Experimental; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Triple Negative Breast Neoplasms

2015
Stratifying triple-negative breast cancer prognosis using 18F-FDG-PET/CT imaging.
    Breast cancer research and treatment, 2015, Volume: 153, Issue:3

    Topics: Adult; Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed; Triple Negative Breast Neoplasms; Tumor Burden

2015
¹⁸F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016, Volume: 57, Issue:4

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Treatment Outcome; Triple Negative Breast Neoplasms

2016
(18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; New York; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Rate; Triple Negative Breast Neoplasms

2016
FDG-based quantitative comparison of glucose metabolism in vitro, exemplified by a head-to-head comparison between a triple-negative breast cancer cell line and a non-malignant foetal cell line.
    Clinical physiology and functional imaging, 2018, Volume: 38, Issue:1

    Topics: Adenosine Triphosphate; Cell Line, Tumor; Cell Proliferation; Culture Media, Conditioned; Energy Metabolism; Female; Fluorodeoxyglucose F18; HEK293 Cells; Humans; Hydrogen-Ion Concentration; Kidney; Lactic Acid; Radiopharmaceuticals; Time Factors; Triple Negative Breast Neoplasms; Tumor Hypoxia; Tumor Microenvironment

2018